Back to results
US 11,642,373 B2Granted
Cancer-killing cells
AssigneeLIfT BioSciences Ltd
InventorsAlex Blyth, Nico Bruyniks
Life of this patent
Estimating the term…
Abstract
The present invention relates to an in vitro culture of haematopoietic cells, wherein said haematopoietic cells differentiate to form granulocytes characterised by the ability to kill cancer cells. The invention also relates to said granulocytes, methods for identifying said haematopoietic cells and granulocytes, compositions and kits comprising the same, as well as uses of the same for treating cancer.
Claims20
A method of formulating a cancer-cell killing formulation comprising:
- selecting hematopoietic stem and/or precursor cells derived from a donor that produces granulocytes with the ability to kill cancer cells;
- and
- formulating the selected hematopoietic stem and/or precursor cells within a carrier;
- thereby formulating the cancer-cell killing formulation.
1 more element
A method of formulating a cancer-cell killing formulation comprising:
- selecting hematopoietic stem and/or precursor cells derived from a donor that produces granulocytes with the ability to kill cancer cells;
- differentiating the selected hematopoietic stem and/or precursor cells into granulocytes, and formulating the granulocytes within a carrier;
- thereby formulating the cancer-cell killing formulation.
Dependencies are inferred from the claim text.